Odyssey Therapeutics, Inc.(ODTX): IPO Breaks Issue After Aggressive Upsizing
Odyssey Therapeutics has successfully concluded its initial public offering (IPO), significantly increasing its share volume after an aggressive upsizing. This marks a notable event in the biotech sector as companies seek to leverage market conditions.
Odyssey Therapeutics IPO biotech market conditions aggressive upsizing